Compound Description
| ID: C0035 | Common name: Dronabinol |
| IUPAC: (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | CAS: CAS:1972-08-3 |
| Chembl ID: CHEMBL465 | Pubchem ID: CID:16078 |
| Formula: C21H30O2 | TCM-ID: TCMC1086 |
| Smiles: CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O | |
| Alias:
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-;
Cannabinol, tetrahydro-; Cannabinol, Δ1-tetrahydro-; (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; (-)-3,4-trans-Δ1-Tetrahydrocannabinol; (-)-trans-Δ1-Tetrahydrocannabinol; (-)-trans-Δ9-THC; (-)-trans-Δ9-Tetrahydrocannabinol; (-)-Δ1-Tetrahydrocannabinol; (-)-Δ9-THC; (-)-Δ9-Tetrahydrocannabinol; (-)-Δ9-trans-Tetrahydrocannabinol; (6AR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,1Oa-tetrahydro-6H-benzo[c]chromen-1-ol; (l)-Δ1-Tetrahydrocannabinol; Abbott 40566; Cannabinoids, THC; Dronabinol; Marinol; NSC 134454; Namisol; QCD 84924; SP 104; THC; Tetrahydrocannabinol; l-trans-Δ9-Tetrahydrocannabinol; l-Δ1-trans-Tetrahydrocannabinol; trans-(-)-Δ9-Tetrahydrocannabinol; trans-Δ9-Tetrahydrocannabinol; Δ1-THC; Δ1-Tetrahydrocannabinol; Δ9-THC; Δ9-Tetrahydrocannabinol; Δ9-trans-Tetrahydrocannabinol |
Structure:
|
Related Targets (Total: 24)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T17E49 | Cannabinoid receptor 1 | CNR1 |
P21554 |
A | 1 Reference(s) |
| T05O6O | Estrogen receptor beta | ESR2 |
Q92731 |
A | 1 Reference(s) |
| T15P3B | Transient receptor potential cation channel subfamily V member 2 | TRPV2 |
Q9Y5S1 |
A | 1 Reference(s) |
| T63BQU | Cytochrome P450 1A1 | CYP1A1 |
P04798 |
A | 1 Reference(s) |
| T02QBS | Cytochrome P450 1A2 | CYP1A2 |
P05177 |
A | 1 Reference(s) |
| T69XVX | Cytochrome P450 1B1 | CYP1B1 |
Q16678 |
A | 1 Reference(s) |
| T23TJV | Tyrosine 3-monooxygenase | TH |
P07101 |
B | 1 Reference(s) |
| T51UV4 | Trans-acting T-cell-specific transcription factor GATA-3 | GATA3 |
P23771 |
B | 1 Reference(s) |
| T04MBA | Vascular endothelial growth factor receptor 2 | KDR |
P35968 |
B | 1 Reference(s) |
| T83YZD | Acetylcholinesterase | ACHE |
P22303 |
B | 1 Reference(s) |
| T37Q9V | Serotonin N-acetyltransferase | AANAT |
Q16613 |
B | 1 Reference(s) |
| T80GUN | 72 kDa type IV collagenase | MMP2 |
P08253 |
B | 1 Reference(s) |
| T63GUB | Proto-oncogene c-Fos | FOS |
P01100 |
B | 1 Reference(s) |
| T48ZIG | D(2) dopamine receptor | DRD2 |
P14416 |
B | 1 Reference(s) |
| T50GQE | Interleukin-13 | IL13 |
P35225 |
C | 1 Reference(s) |
| T76TED | Pro-opiomelanocortin | POMC |
P01189 |
C | 1 Reference(s) |
| T05WWN | Corticoliberin | CRH |
P06850 |
C | 1 Reference(s) |
| T23WMS | Cathepsin D | CTSD |
P07339 |
C | 1 Reference(s) |
| T12WTT | Interleukin-5 | IL5 |
P05113 |
C | 1 Reference(s) |
| T31P1D | Metalloproteinase inhibitor 1 | TIMP1 |
P01033 |
C | 1 Reference(s) |
| T50V79 | Interleukin-4 | IL4 |
P05112 |
C | 1 Reference(s) |
| T34DZ7 | Interleukin-2 | IL2 |
P60568 |
C | 1 Reference(s) |
| T50WOV | ATP-dependent translocase ABCB1 | ABCB1 |
P08183 |
C | 1 Reference(s) |
| T88TDZ | RAC-alpha serine/threonine-protein kinase | AKT1 |
P31749 |
C | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 2)
Ckey description of the interaction between compound and target